XML 110 R92.htm IDEA: XBRL DOCUMENT v3.24.1
STOCK-BASED COMPENSATION (Details Narrative) - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Share-based payment arrangement, expense $ 452,071 $ 1,282,757  
Number of shares of common stock authorized and reserved 333,750    
Options, available for grant 137,042    
Stock options granted, value $ 0 22,768  
Aggregate intrinsic value 0 0  
Aggregate intrinsic value of options exercisable 0 $ 0  
Restricted Stock Units (RSUs) [Member]      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Unrecognized portion of stock compensation expense $ 140,573    
2005 Stock Option Plan [Member] | During 2015 [Member]      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Shares unavailable for issuance 1,078    
Shares unexercised and outstanding 284    
2006 Stock Option Plan [Member] | During 2016 [Member]      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Shares unavailable for issuance 2,739    
Shares unexercised and outstanding 531    
2007 Stock Option Plan [Member]      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Shares unexercised and outstanding 0    
2007 Stock Option Plan [Member] | During 2017 [Member]      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Shares unavailable for issuance 4,733    
2008 Plan [Member]      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Shares unexercised and outstanding 0    
2008 Plan [Member] | During 2018 [Member]      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Shares unavailable for issuance 2,025    
2020 Stock Option Plan [Member] | Restricted Stock [Member]      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Number of shares of common stock authorized and reserved   125,000 125,000
Options, available for grant     112,958